Metacrine News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Metacrine. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Metacrine Today - Breaking & Trending Today
Shares of Metacrine, Inc. (NASDAQ:MTCR – Get Rating) traded up 1.3% on Thursday . The company traded as high as $0.56 and last traded at $0.56. 81,778 shares traded hands during trading, a decline of 72% from the average session volume of 288,585 shares. The stock had previously closed at $0.55. Metacrine Price Performance The […] ....
Metacrine (NASDAQ:MTCR – Get Rating) will be posting its quarterly earnings results on Thursday, April 13th. Metacrine Stock Up 1.6 % NASDAQ MTCR traded up $0.01 on Wednesday, reaching $0.57. The company had a trading volume of 32,406 shares, compared to its average volume of 348,464. The company has a quick ratio of 12.15, a […] ....
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ( KSF ) are investigating the proposed merger of ....
07.09.2022 - Halper Sadeh LLP, an investor rights law firm, is investigating whether the merger of Metacrine Inc. (NASDAQ: MTCR) and Equillium, Inc. is fair to Metacrine shareholders. Halper Sadeh encourages Metacrine shareholders to click here to learn more . ....
Metacrine (NASDAQ:MTCR – Get Rating) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research report issued on Thursday, Zacks.com reports. According to Zacks, “Metacrine Inc. is a clinical-stage biopharmaceutical company. It is focused on discovering and developing therapies for patients with liver and gastrointestinal diseases. The company’s […] ....